MR-HIFU (Magnetic Resonance Imaging-guided High Intensity Focused Ultrasound) is an early-stage, noninvasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with painful metastatic cancer to the bone. This novel technology focuses beams of ultrasound energy precisely and accurately on targets deep in the body without damaging surrounding normal tissue. Where the beams converge, focused ultrasound produces precise ablation (thermal destruction of tissue) of the pain-producing nerves around the cancer metastases without surgery, resulting in a significant reduction in pain.
MR-HIFU is approved as a safe treatment for patients with painful bone metastases. In this project, we will evaluate the role of MR-HIFU in the first line treatment of painful bone metastases.